213 related articles for article (PubMed ID: 22699850)
21. Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration.
Wang JZ; Xia YY; Grundke-Iqbal I; Iqbal K
J Alzheimers Dis; 2013; 33 Suppl 1():S123-39. PubMed ID: 22710920
[TBL] [Abstract][Full Text] [Related]
22. Carboxyl-terminal fragments of presenilin-1 are closely related to cytoskeletal abnormalities in Alzheimer's brains.
Tomidokoro Y; Ishiguro K; Igeta Y; Matsubara E; Kanai M; Shizuka M; Kawarabayashi T; Harigaya Y; Kawakatsu S; Ii K; Ikeda M; St George-Hyslop PH; Hirai S; Okamoto K; Shoji M
Biochem Biophys Res Commun; 1999 Mar; 256(3):512-8. PubMed ID: 10080929
[TBL] [Abstract][Full Text] [Related]
23. Argyrophilic grains are not always argyrophilic--distinction from neurofibrillary tangles of diffuse neurofibrillary tangles with calcification revealed by comparison between Gallyas and Campbell-Switzer methods.
Uchihara T; Tsuchiya K; Nakamura A; Akiyama H
Acta Neuropathol; 2005 Aug; 110(2):158-64. PubMed ID: 15971055
[TBL] [Abstract][Full Text] [Related]
24. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease.
Mukaetova-Ladinska EB; Harrington CR; Roth M; Wischik CM
Am J Pathol; 1993 Aug; 143(2):565-78. PubMed ID: 8342603
[TBL] [Abstract][Full Text] [Related]
25. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
26. [Alzheimer's disease: lesions and their progression].
Duyckaerts C; Colle MA; Delatour B; Hauw JJ
Rev Neurol (Paris); 1999; 155 Suppl 4():S17-27. PubMed ID: 10637934
[TBL] [Abstract][Full Text] [Related]
27. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
Walton JR
J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457
[TBL] [Abstract][Full Text] [Related]
28. [Neurofibrillary tangles and early modification of the neuronal cytoskeleton in Alzheimer's disease and in experimental models].
Brion JP
Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):287-94. PubMed ID: 10992876
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylation of neuronal cytoskeletal proteins in Alzheimer's disease and Lewy body dementias.
Trojanowski JQ; Lee VM
Ann N Y Acad Sci; 1994 Dec; 747():92-109. PubMed ID: 7847694
[No Abstract] [Full Text] [Related]
30. The pathological process underlying Alzheimer's disease in individuals under thirty.
Braak H; Del Tredici K
Acta Neuropathol; 2011 Feb; 121(2):171-81. PubMed ID: 21170538
[TBL] [Abstract][Full Text] [Related]
31. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
Swerdlow RH
Neurobiol Aging; 2007 Oct; 28(10):1465-80. PubMed ID: 16876913
[TBL] [Abstract][Full Text] [Related]
32. Research towards tau imaging.
Jensen JR; Cisek K; Funk KE; Naphade S; Schafer KN; Kuret J
J Alzheimers Dis; 2011; 26 Suppl 3():147-57. PubMed ID: 21971459
[TBL] [Abstract][Full Text] [Related]
33. High-Molecular-Weight Paired Helical Filaments from Alzheimer Brain Induces Seeding of Wild-Type Mouse Tau into an Argyrophilic 4R Tau Pathology in Vivo.
Audouard E; Houben S; Masaracchia C; Yilmaz Z; Suain V; Authelet M; De Decker R; Buée L; Boom A; Leroy K; Ando K; Brion JP
Am J Pathol; 2016 Oct; 186(10):2709-22. PubMed ID: 27497324
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein E immunoreactivity in neurons and neurofibrillary degeneration of aged non-demented and Alzheimer's disease patients.
Gómez-Ramos P; Mufson EJ; Morán MA
Microsc Res Tech; 2001 Oct; 55(1):48-58. PubMed ID: 11596149
[TBL] [Abstract][Full Text] [Related]
35. Pretangles and neurofibrillary changes: similarities and differences between AD and CBD based on molecular and morphological evolution.
Uchihara T
Neuropathology; 2014 Dec; 34(6):571-7. PubMed ID: 24612177
[TBL] [Abstract][Full Text] [Related]
36. [Tau, amyloid and Alzheimer's disease].
Olesen OF
Ugeskr Laeger; 1994 Feb; 156(8):1116-7, 1121-4. PubMed ID: 8116089
[TBL] [Abstract][Full Text] [Related]
37. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads.
Braak E; Braak H; Mandelkow EM
Acta Neuropathol; 1994; 87(6):554-67. PubMed ID: 7522386
[TBL] [Abstract][Full Text] [Related]
38. Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice.
Ishihara T; Zhang B; Higuchi M; Yoshiyama Y; Trojanowski JQ; Lee VM
Am J Pathol; 2001 Feb; 158(2):555-62. PubMed ID: 11159192
[TBL] [Abstract][Full Text] [Related]
39. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?
Grinberg LT; Rüb U; Ferretti RE; Nitrini R; Farfel JM; Polichiso L; Gierga K; Jacob-Filho W; Heinsen H;
Neuropathol Appl Neurobiol; 2009 Aug; 35(4):406-16. PubMed ID: 19508444
[TBL] [Abstract][Full Text] [Related]
40. Tau protein in Alzheimer’s disease.
Maccioni RB
Curr Alzheimer Res; 2011 Sep; 8(6):607. PubMed ID: 21827396
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]